Sai Life Sciences Limited has informed the Exchange about Transcript for the Un-audited Financial Results for the quarter and nine months ended on 3 December 2025.

Investor Communications View source PDF Explain this filing

SAILIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.1%Reaction day

₹927.20

prior close

₹917.70

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-1.6%+0.5% vs market

Pharmaceuticals peers, median of 156sector-0.9%-0.2% vs sector

On the reaction day the stock moved 0.5 pts more than Nifty Smallcap 250 and 0.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

-0.2

15m

+0.1

30m

-0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.1-1.6+0.5-0.9-0.2

Next day

-0.8-1.7+0.9-1.5+0.7

+0.8-0.9+1.8-0.9+1.8

+1.6-0.4+2.0-0.5+2.1

+0.9-1.6+2.6-2.1+3.1

+1.9-1.8+3.7-2.3+4.2

+2.0-2.0+4.0-3.2+5.3

15d

+9.2-7.3+16.5-6.9+16.1

+1.9-8.6+10.5-8.9+10.9

+6.9-3.5+10.4-3.5+10.4

+18.2+3.3+14.9+0.8+17.4

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sai Life Sciences has informed NSE and BSE that the transcript of its Q3 FY26 earnings call, held on 6 February 2026, has been uploaded on the company's website. The filing is a routine compliance disclosure under SEBI's Listing Regulations and does not itself contain financial figures. The actual transcript is available as a PDF on the company's website for shareholders and analysts to review.

Likely market impact

This is a procedural filing with no direct impact on the stock. Investors seeking colour on margins, revenue, order book, or guidance from Q3 FY26 will need to read the attached transcript on the company's website.